{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:18:10Z","timestamp":1790705890546,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Sickle cell disease (SCD) is accompanied by several complications, which emanate from the sickling of erythrocytes due to a point mutation in the <jats:italic>\u03b2<\/jats:italic>-globin chain of hemoglobin. Sickled erythrocytes are unable to move smoothly through small blood capillaries and therefore, cause vaso occlusion and severe pain. Apart from pain, continuous lysis of fragile sickled erythrocytes leads to the release of heme, which is a strong activator of the NLRP3 inflammasome, thus producing chronic inflammation in sickle cell disease. In this study, we identified flurbiprofen among other COX-2 inhibitors to be a potent inhibitor of heme-induced NLRP3 inflammasome. We found that apart from being a nociceptive agent, flurbiprofen exerts a strong anti-inflammatory effect by suppressing NF-\u03baB signaling, which was evidenced by reduced levels of TNF-<jats:italic>\u03b1<\/jats:italic> and IL-6 in wild-type and sickle cell disease Berkeley mice models. Our data further demonstrated the protective effect of flurbiprofen on liver, lungs, and spleen in Berkeley mice. The current sickle cell disease pain management regime relies mainly on opiate drugs, which is accompanied by several side effects without modifying the sickle cell disease-related pathology. Considering the potent role of flurbiprofen in inhibiting NLRP3 inflammasome and other inflammatory cytokines in sickle cell disease, our data suggests that it can be explored further for better sickle cell disease pain management along with the possibility of disease modification.<\/jats:p>","DOI":"10.3389\/fphar.2023.1123734","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:56:25Z","timestamp":1682484985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Flurbiprofen inhibits heme induced NLRP3 inflammasome in Berkeley sickle cell disease mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Dilpreet","family":"Kour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehboob","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Khajuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuhu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palash","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhleen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ramajayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali S.","family":"Bharate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghapal D.","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Srinivasa","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-12-397220-0.00004-0","article-title":"Flurbiprofen","volume":"37","author":"Abdel-Aziz","year":"2012","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"695712","DOI":"10.3389\/fphar.2021.695712","article-title":"IIIM-941, a stilbene derivative inhibits NLRP3 inflammasome activation by inducing autophagy","volume":"12","author":"Ali","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF02703705","article-title":"Liver and kidney toxicity in chronic use of opioids: An experimental long term treatment model","volume":"30","author":"Atici","year":"2005","journal-title":"J. Biosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American society of hematology 2020 guidelines for sickle cell disease: Management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv."},{"key":"B6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/00003495-197918060-00001","article-title":"Flurbiprofen: A review of its pharmacological properties and therapeutic use in rheumatic diseases","volume":"18","author":"Brogden","year":"1979","journal-title":"Drugs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0002-9343(86)90134-8","article-title":"European experience with flurbiprofen. A new analgesic\/anti-inflammatory agent","volume":"80","author":"Buchanan","year":"1986","journal-title":"Am. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1182\/blood-2013-10-529982","article-title":"Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3233\/CH-189012","article-title":"Inflammation in sickle cell disease","volume":"68","author":"Conran","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E4110","DOI":"10.1073\/pnas.1405023111","article-title":"Hemolysis-induced lethality involves inflammasome activation by heme","volume":"111","author":"Dutra","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: A caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat. Immunol."},{"key":"B12","first-page":"611","article-title":"Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease","volume":"84","author":"Francis","year":"1992","journal-title":"J. Natl. Med. Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1182\/blood-2018-11-886259","article-title":"Resolving inflammation and pain of sickle cell","volume":"133","author":"Fredman","year":"2019","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1182\/blood-2014-03-563874","article-title":"Erythroid DAMPs drive inflammation in SCD","volume":"123","author":"Gladwin","year":"2014","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"115582","DOI":"10.1016\/j.taap.2021.115582","article-title":"Safranal inhibits NLRP3 inflammasome activation by preventing ASC oligomerization","volume":"423","author":"Gupta","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1182\/blood.v65.3.513.bloodjournal653513","article-title":"Leukocyte-endothelial interactions","volume":"65","author":"Harlan","year":"1985","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/jcp.24815","article-title":"Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1\u03b2 production","volume":"230","author":"Hua","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-med-120611-143127","article-title":"Sickle cell disease, vasculopathy, and therapeutics","volume":"64","author":"Kassim","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B21","doi-asserted-by":"publisher","first-page":"12169","DOI":"10.1073\/pnas.1509158112","article-title":"Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation","volume":"112","author":"Keleku-Lukwete","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/intimm\/dxx018","article-title":"Mechanisms governing inflammasome activation, assembly and pyroptosis induction","volume":"29","author":"Kesavardhana","year":"2017","journal-title":"Int. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2018-11-884346","article-title":"Sensitization of nociceptors by prostaglandin E2-glycerol contributes to hyperalgesia in mice with sickle cell disease","volume":"133","author":"Khasabova","year":"2019","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.clpt.2003.10.007","article-title":"Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease","volume":"75","author":"Kopecky","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1beta secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000204452","article-title":"Levels of tumor necrosis factor alpha\/cachectin (TNF alpha) in sera from patients with sickle cell disease","volume":"90","author":"Malave","year":"1993","journal-title":"Acta Haematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fimmu.2020.00454","article-title":"The red blood cell-inflammation vicious circle in sickle cell disease","volume":"11","author":"Nader","year":"2020","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/JIR.S51250","article-title":"Targeting the NLRP3 inflammasome in chronic inflammatory diseases: Current perspectives","volume":"8","author":"Ozaki","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ajh.20196","article-title":"Cytokine profile of sickle cell disease in Oman","volume":"77","author":"Pathare","year":"2004","journal-title":"Am. J. Hematol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cyto.2016.03.016","article-title":"Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell","volume":"83","author":"Pitanga","year":"2016","journal-title":"Cytokine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0769-2625(88)90149-3","article-title":"TNF as an activator of vascular endothelium","volume":"139","author":"Pober","year":"1988","journal-title":"Ann. Inst. Pasteur Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/j.1742-1241.2007.01452.x","article-title":"Flurbiprofen in the symptomatic management of rheumatoid arthritis: A valuable alternative","volume":"61","author":"Richy","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1182\/blood-2019-03-900944","article-title":"Blocking COX-2 for sickle cell pain relief","volume":"133","author":"Sadler","year":"2019","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/CIRCRESAHA.116.304577","article-title":"Iron, inflammation, and early death in adults with sickle cell disease","volume":"116","author":"Van Beers","year":"2015","journal-title":"Circ. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/bloodadvances.2018021709","article-title":"The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1\/TLR4 and Bruton tyrosine kinase","volume":"2","author":"Vogel","year":"2018","journal-title":"Blood Adv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/MPH.0b013e3181acd89d","article-title":"Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease","volume":"31","author":"Wanderer","year":"2009","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"F1388","DOI":"10.1152\/ajprenal.00389.2007","article-title":"Morphine induces mesangial cell proliferation and glomerulopathy via kappa-opioid receptors","volume":"294","author":"Weber","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1182\/blood-2014-04-560813","article-title":"Sickle cell disease increases high mobility group box 1: A novel mechanism of inflammation","volume":"124","author":"Xu","year":"2014","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41418-018-0105-8","article-title":"lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation","volume":"26","author":"Xue","year":"2019","journal-title":"Cell. Death Differ."},{"key":"B42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell. Death Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature15367","article-title":"Neutrophil ageing is regulated by the microbiome","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1159\/000478070","article-title":"Activation of COX-2\/mPGES-1\/PGE2 cascade via NLRP3 inflammasome contributes to albumin-induced proximal tubule cell injury","volume":"42","author":"Zhuang","year":"2017","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1123734\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:56:29Z","timestamp":1682484989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1123734\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":45,"alternative-id":["10.3389\/fphar.2023.1123734"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1123734","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"article-number":"1123734"}}